Sonova has had a PPA conducted for the acquisition of AudioNova
In September 2016, Sonova, the world’s leading provider of hearing solutions, acquired AudioNova. Subsequent to the transaction, a purchase price allocation (PPA) was conducted for accounting purposes.
Sonova, headquartered in Stäfa, Switzerland, is the leading provider of innovative hearing care solutions. The group operates through its core business brands Phonak, Unitron, Hansaton and Advanced Bionics. Sonova offers its customers one of the most comprehensive product portfolios in the industry – from hearing instruments to cochlear implants and wireless communication solutions. Founded in 1947, the group is currently present in over 100 countries across the globe and has a workforce of over 14,000 dedicated employees.
AudioNova is one of Europe’s leading hearing aid retailers and service providers. With its highly qualified staff, including 1,600 acousticians, the company assists its clients with the selection of the best hearing solution for their needs, ensuring actual use through continuous support, thus improving quality of life through better hearing. In addition to AudioNova, the group also operates under brands such as Audium, AuditionSanté, Boots Hearingcare, Connect Hearing, Fiebing, Geers, Hansaton, Lapperre, Lindacher, Schoonenberg, Triton and Vitakustik.
Oaklins' team in Switzerland advised Sonova during the post-transaction phase and produced a PPA report in accordance with IFRS 3. The report contained the allocation of the consideration paid to all identifiable assets acquired and liabilities assumed.
Thomas Lenz
Senior Manager Corporate Controlling, Sonova
Talk to the deal team
Related deals
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Learn more